The management of asymptomatic carotid stenosis remains controversial. From December 1983 to December 1987, 188 symptom-free patients were found to have severe (>75%) stenosis by duplex imaging (performed as screening examination). Patients with nonhemispheric symptoms or contralateral symptomatic lesions (within 7 years) were excluded from the study. Follow-up data were available for 141 patients (range 3 to 36 months; mean 21 months). Sixty-two patients received nonoperative therapy. The remaining 79 patients underwent 100 carotid endarterectomies (CAE) (21 staged bilateral repairs and 58 unilateral repairs). There were no statistically significant differences in sex, age, or risk factors (i.e., hypertension, diabetes, or smoking) or in the incidence of bilateral disease. Significant differences were found in the incidence ofischemic attacks (0 vs 21%; p < 0.001) and stroke (2.5% vs 18%; p < 0.01) in the operative vs nonoperative group. None of the 11 strokes in the nonoperative group were preceded by neurologic events. The operative group had an overall stroke rate of 2.5% (2/79), a perioperative mortality rate of 1.3% (1/79), and a restenosis (>50%) rate of 3.8% (3/79). Thus favorable results can be achieved with prophylactic CAE. These data support the use of prophylactic CAE in any patient with greater than 75% stenosis identified by duplex image, regardless of sex, age, risk factors, or bilateral disease. (J VAsc SURG 1989;9:361-6.) Controversy exists over prophylactic carotid endarterectomy (CAE) in symptom-free patients. The Framingham study 1 and others 2 suggest a stroke risk of 0.1% to 0.4% per year in symptom-free patients. The marker of disease in these studies was the presence of a bruit and not necessarily documented stenosis. When a stenosis is found, however, the risk of stroke increases to 0.7% to 6%Y Recent reports by Hertzer et al. 6 and Moneta et al. 7 have demonstrated a beneficial result ofendarterectomy in reducing transient ischemic attacks (TEAs) and stroke in symptomfree patients with >75% diameter stenosis. However, Hertzer et al. could demonstratc a reduction of _~roke risk only in symptom-free male patients. Still others report no benefit of prophylactic endarterectomy in any patients. 3-5,s-~° Because the presence of a bruit does not correlate well with significant internal carotid stenosis, s'9 other screening maneuvers have been developed. Noninvasive tests, in particular duplex scanning, has been well documented to be a reliable screening tool for the detection of carotid stenosis, n The results of du-From the
The management of asymptomatic carotid stenosis remains controversial. From December 1983 to December 1987, 188 symptom-free patients were found to have severe (greater than 75%) stenosis by duplex imaging (performed as screening examination). Patients with non-hemispheric symptoms or contralateral symptomatic lesions (within 7 years) were excluded from the study. Follow-up data were available for 141 patients (range 3 to 36 months; mean 21 months). Sixty-two patients received nonoperative therapy. The remaining 79 patients underwent 100 carotid endarterectomies (CAE) (21 staged bilateral repairs and 58 unilateral repairs). There were no statistically significant differences in sex, age, or risk factors (i.e., hypertension, diabetes, or smoking) or in the incidence of bilateral disease. Significant differences were found in the incidence of ischemic attacks (0 vs 21%; p less than 0.001) and stroke (2.5% vs 18%; p less than 0.01) in the operative vs nonoperative group. None of the 11 strokes in the nonoperative group were preceded by neurologic events. The operative group had an overall stroke rate of 2.5% (2/79), a perioperative mortality rate of 1.3% (1/79), and a restenosis (greater than 50%) rate of 3.8% (3/79). Thus favorable results can be achieved with prophylactic CAE. These data support the use of prophylactic CAE in any patient with greater than 75% stenosis identified by duplex image, regardless of sex, age, risk factors, or bilateral disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.